MOLECULA
Selank (10mg)
Peptides
€20.00
0
Buy with consultation
Concentration:
10 mg
Volume:
5 vials
Buy Selank 5 vials 10mg Peptides online. Premium peptide for anxiety reduction, mood balance, focus, performance, and well-being.
Description
Selank is a synthetic heptapeptide analog of Tuftsin (TP-7), developed as a nootropic and anxiolytic peptide. It is widely studied for its ability to reduce anxiety, improve mood, and enhance cognitive function without the sedative or addictive side effects of traditional anxiolytics like benzodiazepines. Why Selank Stands Out Selank acts on the GABA and serotonin systems, supporting emotional balance while also enhancing learning and memory. Its immunomodulatory properties add further value for research into stress-related and cognitive disorders: Anxiolytic Action: Reduces anxiety and stabilizes mood Cognitive Enhancement: Improves focus, memory, and learning Immunomodulation: Supports immune balance under stress Key Benefits of Selank Reduces anxiety, stress, and depressive-like symptoms Improves cognitive function, memory, and learning Enhances serotonin and dopamine balance Non-sedating, non-addictive alternative to benzodiazepines Supports immune system regulation Potential in generalized anxiety disorder (GAD) research Application & Dosage Guidelines Dosage Range (Research Use): 250 mcg – 500 mcg daily (varies by study) Administration: Intranasal or subcutaneous injection (research use only) Frequency: Daily or as per research protocol Reconstitution: Mix with bacteriostatic or sterile water for injection Storage: Keep refrigerated after mixing (up to 10 days) Safety & Side Effects All dosing information is for research purposes only and not for human consumption unless prescribed by a licensed professional. Possible dose-dependent effects may include: Temporary nasal irritation (if intranasal) Mild fatigue or drowsiness in some cases Rare mood fluctuations Research highlights Selank’s unique profile as an anti-anxiety, mood-stabilizing, and cognitive-enhancing peptide, making it a promising candidate for further studies in psychiatry and neurology.
MOLECULA · 2026